Cicely Chen, MD
Obstetrics & Gynecology · Sonora, CANPI 1043625916
Payments from drug & device makers
Across 49 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$141
- Daiichi Sankyo Inc.$135
- Astellas Pharma US Inc$104
- Hologic Sales And Service, LLC$101
- Myriad Women's Health, Inc.$63
- Supernus Pharmaceuticals, Inc.$55
- plus $449 from 18 others
What the payments were for
- Consulting fees$141%
- Food & beverage$1,01096%
- Education$232%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 7 | $141 |
| Daiichi Sankyo Inc. | 7 | $135 |
| Astellas Pharma US Inc | 5 | $104 |
| Hologic Sales And Service, LLC | 4 | $101 |
| Myriad Women's Health, Inc. | 1 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Roche Diagnostics Corporation | 3 | $53 |
| Boston Scientific | 1 | $41 |
| Bayer | 2 | $36 |
| Baxter Healthcare | 1 | $35 |
| Organon | 2 | $33 |
| Smith+Nephew | 1 | $29 |
| Teleflex LLC | 1 | $29 |
| Intuitive Surgical | 1 | $28 |
| AMAG Pharmaceuticals, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $19 |
| LSI Solutions Inc | 1 | $16 |
| Aspira Women's Health Inc | 1 | $14 |
| Avanos Medical | 1 | $14 |
| Bard Access Systems, Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$1,047 in reported general payments places this provider in the 65th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 91 | $3,852 |
| Clobetasol Propionate | 12 | $467 |
| Acyclovir | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Sonora
- Peyman BanooniBeverly Hills$9.2M
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
- Vanessa JacobySan Francisco$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.